NZ Super Fund takes leading stake in fertility company

The NZ Super Fund has joined a group of investors to take a 70 per cent stake in fertility treatment provider Fertility Associates.

The 30 per cent balance of the business will continue to be owned by Fertility Associates’ doctors and management team.

Fertility Associates was founded in 1987 and is a provider of reproductive support, diagnostic services and fertility treatments in New Zealand and Malaysia.

Del Hart​, head of external investments and partnerships at NZ Super Fund said she was pleased to invest in a quality local business that had helped bring more than 30,000 babies into the world.

READ MORE:
* Fertility clinic ordered to apologise for disposing of woman’s frozen embryos
* How NZ’s super-rich made their money
* NZ Super Fund increases investment in primary sector

The fund is joined in the investment by investors including Pioneer Capital and Comprador Holdings.

“Our investment in Fertility Associates gives us exposure to the New Zealand healthcare sector and fits with our focus of identifying local businesses where we can add value by investing to help them grow and develop,” Hart​ said.

Pioneer Capital’s investment comes from its fourth private equity fund which is invested in high growth, mid-market New Zealand businesses seeking international growth.

Comprador Holdings has extensive experience in the fertility sector from a previous investment in British fertility business The Fertility Partnership.

Del Hart, head of external investments and partnerships at NZ Super Fund, says she is pleased to invest ni quality local business that had helped bring over 30,000 babies into the world.

SUPPLIED/Stuff

Del Hart, head of external investments and partnerships at NZ Super Fund, says she is pleased to invest ni quality local business that had helped bring over 30,000 babies into the world.

Hart​ said the international experience in the investment consortium would be crucial to expanding its international services into other Asia-Pacific countries.

Alex Price​, chief executive of Fertility Associates, welcomed the investment.

“The last two years have had their challenges, but the investment does represent an important vote of confidence in Fertility Associates’ future,” Price​ said.

Source link